Oncology Supercharging clinical trials with data and AI: Realyze’s Aa... At ASCO 2025, Realyze CEO Aaron Brauser talks transforming clinical trial screening with AI, NLP and real-world data use.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
